What is the official website of Sandoz Iberia ?

The official website of Sandoz Iberia is https://sandozfarma.es/.

What is Sandoz Iberia's cybersecurity risk score?

Sandoz Iberia has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Iberia experienced?

According to Rankiteo, Sandoz Iberia currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Iberia been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Iberia has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Iberia have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Iberia is not certified under SOC 2 Type 1.

Does Sandoz Iberia have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Iberia does not hold a SOC 2 Type 2 certification.

Does Sandoz Iberia comply with GDPR ?

According to Rankiteo, Sandoz Iberia is not listed as GDPR compliant.

Does Sandoz Iberia have PCI DSS certification ?

According to Rankiteo, Sandoz Iberia does not currently maintain PCI DSS compliance.

Does Sandoz Iberia comply with HIPAA ?

According to Rankiteo, Sandoz Iberia is not compliant with HIPAA regulations.

Does Sandoz Iberia have ISO 27001 certification ?

According to Rankiteo,Sandoz Iberia is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Iberia operate in ?

Sandoz Iberia operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Iberia have ?

Sandoz Iberia employs approximately 122 people worldwide.

Does Sandoz Iberia own any subsidiaries ?

Sandoz Iberia presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Iberia have ?

Sandoz Iberia's official LinkedIn profile has approximately 19,172 followers.

What is the NAICS classification code for Sandoz Iberia ?

Sandoz Iberia is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Iberia have a Crunchbase profile ?

No, Sandoz Iberia does not have a profile on Crunchbase.

Does Sandoz Iberia have a LinkedIn profile ?

Yes, Sandoz Iberia maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoziberia.

How many cybersecurity incidents has Sandoz Iberia experienced ?

As of July 27, 2026, Rankiteo reports that Sandoz Iberia has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Iberia have ?

Sandoz Iberia has an estimated 5,709 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Iberia

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Sandoz Iberia Vendor Cyber Rating & Cyber Score

sandozfarma.es

Add Your Compliance Badge

En Sandoz, nuestro propósito es ser pioneros en facilitar el acceso a la salud de los pacientes y aspiramos a ser la empresa de genéricos y biosimilares líder y más valorada del mundo. El origen de la compañía se remonta a Basilea, Suiza, en 1886. Nos enorgullecemos de nuestra larga trayectoria, que hoy es sinónimo de calidad, fiabilidad e innovación. Más de 20.000 personas de 100 nacionalidades trabajamos juntas para garantizar que Sandoz proporcione 900 millones de tratamientos a pacientes anuales, lo que genera un ahorro sanitario y un impacto social aún mayor. Somos el número 1 en el mercado mundial de genéricos si se comparan las ventas netas, el segundo en biosimilares y la empresa de genéricos líder en Europa. Estamos trabajando

Sandoz Iberia A.I CyberSecurity Scoring

Scoring History

Sandoz Iberia

Sandoz Iberia CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Iberia Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Iberia

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Iberia in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Iberia in 2026.

Incident Types Sandoz Iberia vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Iberia in 2026.

Incident History - Sandoz Iberia (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Iberia Subsidiaries

Sandoz Iberia

Pharmaceutical Manufacturing

Website: https://sandozfarma.es/

Company Size: 501-1,000 employees

SandozPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Sandoz BelgiumPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz in DeutschlandPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Loading…

Sandoz Iberia Similar Companies

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Loading…

NEWS

Sandoz Iberia CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-57990

SUMMARY

Files or directories accessible to external parties in Microsoft Edge (Chromium-based) allows an unauthorized attacker to disclose information over a network.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57990

CVE-2026-57989

SUMMARY

Origin validation error in Microsoft Edge (Chromium-based) allows an unauthorized attacker to disclose information over a network.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57989

CVE-2026-57978

SUMMARY

Origin validation error in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-57978

CVE-2026-17497

SUMMARY

NoteGen before 0.32.0 grants the Tauri shell plugin shell:allow-execute capability for bash, python, and python3 with arbitrary arguments in the default desktop capabilities. JavaScript running in the application webview can therefore invoke plugin:shell|execute to run attacker-controlled operating system commands with the privileges of the NoteGen process. In combination with script execution in the webview (for example via chat XSS), this enables full remote code execution on the user's machine.

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 8.3)

cvss3

Base Score: 8.3

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:H/I:H/A:H

Impact Score

Exploitability

1.6

REFERENCES

CVE-2026-17496

SUMMARY

NoteGen before 0.32.0 renders AI chat responses with markdown-it configured with html:true and injects the result into the DOM via dangerouslySetInnerHTML in chat-preview, without HTML sanitization and with CSP set to null. Attacker-controlled content that reaches the model prompt (for example a malicious skill REFERENCE.md that instructs the model to emit HTML) can cause the model response to include executable markup such as an img onerror handler. When the user views the chat response, that markup runs as JavaScript in the privileged Tauri webview, enabling arbitrary script execution in the application context (cross-site scripting).

Published

Date2026-07-26

Updated

Date2026-07-26

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…